MicroRNA-mediated regulation of T follicular helper and T follicular regulatory cell identity.


Journal

Immunological reviews
ISSN: 1600-065X
Titre abrégé: Immunol Rev
Pays: England
ID NLM: 7702118

Informations de publication

Date de publication:
03 2019
Historique:
received: 10 10 2018
accepted: 21 12 2018
entrez: 16 3 2019
pubmed: 16 3 2019
medline: 31 12 2019
Statut: ppublish

Résumé

T follicular helper (Tfh) cells are critical mediators of germinal center (GC) formation and essential for potent humoral immunity. In contrast, T follicular regulatory (Tfr) cells, which share characteristics of both stimulatory Tfh cells and suppressive regulatory T (Treg) cells, restrain excessive GC responses. Tfh cell differentiation is a multistep process that involves continuous interaction with antigen-presenting cells, co-stimulatory signals, an appropriate cytokine milieu, and directed migration toward distinct microanatomical structures. These processes are under the control of several intrinsic and extrinsic regulatory layers that further undergo fine-tuning by post-transcriptional mechanisms. MicroRNAs (miRNAs) are small, non-coding RNAs that have been recognized as important post-transcriptional regulators. miRNAs are particularly critical for Tfh cell generation, as the differentiation of these cells is completely blocked in the absence of mature miRNAs in vivo. Here, we discuss how miRNAs regulate various aspects of Tfh and Tfr cell differentiation and function and how miRNAs thus shape the identity of these cells.

Identifiants

pubmed: 30874343
doi: 10.1111/imr.12735
doi:

Substances chimiques

MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-111

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Julia Maul (J)

Institute for Immunology, Biomedical Center, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.

Dominik Alterauge (D)

Institute for Immunology, Biomedical Center, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.

Dirk Baumjohann (D)

Institute for Immunology, Biomedical Center, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH